Ogata Keiko, Suto Hidenori, Sato Akira, Maeda Keiko, Minami Kenta, Tomiyama Naruto, Kosaka Tadashi, Hojo Hitoshi, Takahashi Naofumi, Aoyama Hiroaki, Yamada Tomoya
Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka 3-chome, Konohana-ku, Osaka 554-8558, Japan.
Current address: Registration & Regulatory Affairs Department, AgroSolutions Division-International, Sumitomo Chemical Company, Ltd., Tokyo Nihombashi Tower, 2-7-1 Nihonbashi, Chuo-ku, Tokyo 103-6020, Japan.
J Toxicol Pathol. 2024 Oct;37(4):173-187. doi: 10.1293/tox.2024-0004. Epub 2024 Jul 16.
In a past study, we proposed a modified Comparative Thyroid Assay (CTA) with additional examinations of brain thyroid hormone (TH) concentrations and brain histopathology but with smaller group sizes. The results showed that the modified CTA in Sprague Dawley rats detected 10 ppm 6-propylthiouracil (6-PTU)-induced significant suppressions of serum/brain TH concentrations in offspring. To confirm the reliability of qualitative brain histopathology and identify the optimal testing time for heterotopia (a cluster of ectopic neurons) in the modified CTA, brain histopathology together with serum/brain TH concentrations were assessed in GD20 fetuses and PND2, 4, 21, and 28 pups using a similar study protocol but with a smaller number of animals (N=3-6/group/time). Significant hypothyroidism was observed and brain histopathology revealed cerebral heterotopia formation in PND21 and PND28 pups, with likely precursor findings in PND2 and PND4 pups but not in GD20 fetuses. This study confirmed that the optimal testing time for cerebral heterotopia in rat CTA was PND21 and thereafter. These findings suggest that cerebral heterotopia assessment at appropriate times may be a useful alternative to the original CTA design.
在过去的一项研究中,我们提出了一种改良的比较甲状腺检测法(CTA),该方法增加了对脑甲状腺激素(TH)浓度和脑组织病理学的检测,但样本量较小。结果表明,改良后的CTA在斯普拉格-道利大鼠中检测到,10 ppm的6-丙基硫氧嘧啶(6-PTU)可导致后代血清/脑TH浓度显著降低。为了确认定性脑组织病理学的可靠性,并确定改良CTA中异位症(异位神经元簇)的最佳检测时间,我们使用类似的研究方案,但动物数量较少(每组/每次时间点N = 3 - 6只),对GD20胎儿以及出生后第2、4、21和28天的幼崽进行了脑组织病理学以及血清/脑TH浓度的评估。在出生后第21天和第28天的幼崽中观察到明显的甲状腺功能减退,脑组织病理学显示有脑异位症形成,在出生后第2天和第4天的幼崽中可能有前期表现,但在GD20胎儿中未观察到。本研究证实,大鼠CTA中脑异位症的最佳检测时间是出生后第21天及以后。这些发现表明,在适当时间进行脑异位症评估可能是对原始CTA设计的一种有用替代方法。